Paper36326
Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.
Das KM and 3 others. Gastroenterology, 1979. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats. Papers, record 36326. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36326
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Crohn Disease | Major topic |
| Intestinal Absorption | Major topic |
| Liver | Major topic |
| Sulfasalazine | Major topic |
| Animals | |
| Bile | |
| Cats | |
| Humans | |
| Ileostomy | |
| Male | |
| Oxidoreductases | |
| Physiology, Comparative | |
| Rats |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582612 | RUCAM-ascertained immunology and autoimmunity specifics of six idiosyncratic drug-induced liver injury types with refined classification: their individual complex molecular interplay. | Front Immunol | 2026 | https://conductscience.org/library/papers/42582612 | PubMed |
| 41948819 | Translational Modeling of Gut Microbiome-Mediated Drug Metabolism: A Case Example of Sulfasalazine. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/41948819 | PubMed |
| 41096839 | Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096839 | PubMed |
| 37047633 | Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047633 | PubMed |
| 33987428 | Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33987428 | PubMed |
| 27571936 | Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines. | Sci Rep | 2016 | https://conductscience.org/library/papers/27571936 | PubMed |
| 25872459 | Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25872459 | PubMed |
| 25380981 | Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates. | Pharm Res | 2015 | https://conductscience.org/library/papers/25380981 | PubMed |
| 7640156 | Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7640156 | PubMed |
| 6661362 | Kinetics of 5-aminosalicylic acid after jejunal instillation in man. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661362 | PubMed |
| 3319462 | Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas. | Dig Dis Sci | 1987 | https://conductscience.org/library/papers/3319462 | PubMed |
| 3207553 | Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3207553 | PubMed |
| 2882965 | Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. | Dig Dis Sci | 1987 | https://conductscience.org/library/papers/2882965 | PubMed |
| 2877884 | 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2877884 | PubMed |
| 2877850 | Pharmacological and biochemical actions of sulphasalazine. | Drugs | 1986 | https://conductscience.org/library/papers/2877850 | PubMed |
| 2864155 | Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/2864155 | PubMed |
| 2199130 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2199130 | PubMed |
| 1676590 | Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. | Drug Saf | 1991 | https://conductscience.org/library/papers/1676590 | PubMed |
| 1389944 | Drug therapy of ulcerative colitis. | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1389944 | PubMed |
| 1362531 | The three week sulphasalazine syndrome. | Clin Rheumatol | 1992 | https://conductscience.org/library/papers/1362531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36326
GET https://conductscience.org/api/papers/v1/36326/authors